STX-0712
Phase 1- Indications
- Chronic myelomonocytic leukemia, Hematologic malignancies
Company intelligence / Profile preview
HuLow is a private, active healthcare and life science investment firm based in Northbrook, Illinois. Available public information indicates that it invests in early-stage medical products, devices, and technologies rather than operating as a drug-development biotech with a disclosed therapeutic pipeline. The company appears to focus on nurturing and funding health-related innovation and is described by third-party business databases as a healthcare/life science venture investor. Publicly accessible evidence does not show a conventional pharma or biotech pipeline with named clinical assets, targets, or indications. As a result, HuLow is best characterized as a health-focused investment company rather than a therapeutics developer.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HuLow Medical.